Chemical Profiling and Anticancer Potential of Apium graveolens Seed Essential Oil: In Vitro Assessment in Melanoma and Pancreatic Cancer and In Silico Analysis in Melanoma

Although the essential oil (EO) extracted from the seeds of A. graveolens (APM EO) has garnered considerable interest in recent years due to its wide range of biological activities, its cytotoxic effects against melanoma and pancreatic cancer, as well as the molecular targets potentially involved in these effects, remain insufficiently explored. The current study, designed to address this knowledge gap, combines chemical characterization with in vitro and in silico evaluations through network pharmacology and molecular docking of APM EO activity and potential molecular targets. GC-MS revealed the presence of D-limonene as a major component (83.33%) accompanied by β-selinene (4.78%) in a smaller proportion. Cell viability was assessed in A375 melanoma, PANC-1 pancreatic adenocarcinoma and immortalized keratinocyte HaCaT cells following 24 h exposure to 10–250 µg/mL APM EO. Treatment reduced cancer cell viability in a concentration-dependent manner, with IC50 values of 113.02 μg/mL in A375 and 151.9 μg/mL in PANC-1 cells, while HaCaT cells exhibited lower sensitivity (IC50 > 250 μg/mL). Immunofluorescence revealed the occurrence of nuclear condensation and altered β-actin distribution in treated cells, revealing morphological changes suggestive of apoptosis. Network pharmacology identified STAT3 and PTGS2 (COX-2) as potential melanoma-associated targets. Molecular docking revealed favorable predicted binding affinities for β-selinene and α-selinene toward PTGS2 (−8.2 and −8.3 kcal/mol, respectively), caryophyllene oxide yielded a docking score of −5.3 kcal/mol toward STAT3. Overall, the findings provide initial experimental evidence of APM EO activity against melanoma and pancreatic adenocarcinoma cells, together with computational prediction of potential molecular targets in melanoma, and justify the need for future preclinical investigations of APM EO in terms of the experimental validation of its cell death mechanisms, target engagement and selectivity.

Authors

Institutions

Publication Details

Journal
Applied Sciences
Published
2026-11-18
DOI
https://doi.org/10.3390/app162211439
Primary Topic
Essential Oils and Antimicrobial Activity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Chemical Profiling and Anticancer Potential of Apium graveolens Seed Essential Oil: In Vitro Assessment in Melanoma and Pancreatic Cancer and In Silico Analysis in Melanoma

Christian Dragos Banciu, Alexandra Prodea, Ioana Zinuca Pavel, Elisabeta Atyim et al.
2 links
Applied Sciences
Essential Oils and Antimicrobial Activity
article

Chemical Profiling and Anticancer Potential of Apium graveolens Seed Essential Oil: In Vitro Assessment in Melanoma and Pancreatic Cancer and In Silico Analysis in Melanoma

Christian Dragos Banciu, Alexandra Prodea, Ioana Zinuca Pavel, Elisabeta Atyim, Alexandra Teodora Lukinich-Gruia, Andreea Mara Munteanu, Andreea Milan, Alexandra Mioc, Roxana Racoviceanu, Maria-Alexandra Pricop, Codruţa Şoica, Gabriela Antal, Iasmina Denisa Boantă
article en

Abstract

Although the essential oil (EO) extracted from the seeds of A. graveolens (APM EO) has garnered considerable interest in recent years due to its wide range of biological activities, its cytotoxic effects against melanoma and pancreatic cancer, as well as the molecular targets potentially involved in these effects, remain insufficiently explored. The current study, designed to address this knowledge gap, combines chemical characterization with in vitro and in silico evaluations through network pharmacology and molecular docking of APM EO activity and potential molecular targets. GC-MS revealed the presence of D-limonene as a major component (83.33%) accompanied by β-selinene (4.78%) in a smaller proportion. Cell viability was assessed in A375 melanoma, PANC-1 pancreatic adenocarcinoma and immortalized keratinocyte HaCaT cells following 24 h exposure to 10–250 µg/mL APM EO. Treatment reduced cancer cell viability in a concentration-dependent manner, with IC50 values of 113.02 μg/mL in A375 and 151.9 μg/mL in PANC-1 cells, while HaCaT cells exhibited lower sensitivity (IC50 > 250 μg/mL). Immunofluorescence revealed the occurrence of nuclear condensation and altered β-actin distribution in treated cells, revealing morphological changes suggestive of apoptosis. Network pharmacology identified STAT3 and PTGS2 (COX-2) as potential melanoma-associated targets. Molecular docking revealed favorable predicted binding affinities for β-selinene and α-selinene toward PTGS2 (−8.2 and −8.3 kcal/mol, respectively), caryophyllene oxide yielded a docking score of −5.3 kcal/mol toward STAT3. Overall, the findings provide initial experimental evidence of APM EO activity against melanoma and pancreatic adenocarcinoma cells, together with computational prediction of potential molecular targets in melanoma, and justify the need for future preclinical investigations of APM EO in terms of the experimental validation of its cell death mechanisms, target engagement and selectivity.

Applied SciencesVol. 16(22)
Polytechnic University of Timişoara (RO), Spitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Good health and well-being
Essential Oils and Antimicrobial Activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon